Benzinga | Nov 10, 2021 04:39PM EST

Xenon Pharmaceuticals Q3 EPS $(0.36) Beats $(0.38) Estimate, Sales $8.12M Miss $10.22M Estimate

Xenon Pharmaceuticals (NASDAQ:XENE) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.38) by 5.26 percent. This is a 44 percent decrease over losses of $(0.25) per share from the same period last year. The company reported quarterly sales of $8.12 million which missed the analyst consensus estimate of $10.22 million by 20.51 percent. This is a 23.95 percent increase over sales of $6.55 million the same period last year.